On May 29, 2019 Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, reported that Rick Fair, President and CEO, is scheduled to present a corporate overview at the Jefferies 2019 Healthcare Conference on Tuesday, June 4 at 2:00 p.m. EDT in New York City (Press release, Bellicum Pharmaceuticals, MAY 29, 2019, View Source [SID1234536639]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation may be accessed from the News & Events section of the Bellicum website. An archived version of the webcast will be available for replay immediately following the event.

On May 29, 2019 Amgen (NASDAQ: AMGN) reported that it will host a webcast investor meeting at ASCO (Free ASCO Whitepaper) 2019 on Monday, June 3 at 6:30 p.m. CT. David M. Reese, M.D., executive vice president of Research and Development at Amgen, along with members of Amgen’s clinical development team and clinical investigators, will participate at the investor meeting to discuss Amgen’s oncology program and data presented at ASCO (Free ASCO Whitepaper) 2019 including clinical data being presented for the Company’s KRAS G12C inhibitor AMG 510 and BiTE molecules AMG 420 and AMG 212 (Press release, Amgen, MAY 29, 2019, View Source;p=RssLanding&cat=news&id=2400001 [SID1234536638]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Live audio of the investor meeting will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen’s business given at certain investor and medical conferences, can be accessed on Amgen’s website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen’s Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

On May 29, 2019 GlycoMimetics, Inc. (Nasdaq: GLYC) reported that Chief Executive Officer Rachel King will provide a corporate update at the Jefferies 2019 Healthcare Conference, on June 5 at 2:00 p.m. ET. in New York, NY (Press release, GlycoMimetics, MAY 29, 2019, View Source [SID1234536637]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access the live webcast and subsequent archived recordings for this presentation, please visit the GlycoMimetics website at www.glycomimetics.com.

On May 29, 2019 Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated to improving life through the application of its proprietary ARCUS genome editing platform, reported that members of its management team will participate in three upcoming investor conferences during June 2019 (Press release, Precision Biosciences, MAY 29, 2019, View Source [SID1234536636]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Chief Executive Officer, Matt Kane, will present at the Jefferies 2019 Healthcare Conference in New York City, New York. The presentation is scheduled for Friday, June 7, 2019 at 10:00 AM Eastern Time.

Mr. Kane will host a fireside chat at the Goldman Sachs 37th Annual Global Healthcare Conference in Rancho Palos Verdes, California. The presentation is scheduled for Wednesday, June 12, 2019 at 10:40 AM Pacific Time.

Mr. Kane will present at the Raymond James Life Sciences and MedTech Conference in New York City, New York. The presentation is scheduled for Wednesday, June 19, 2019 at 3:00 PM Eastern Time.

A live audio webcast of the presentation from the Raymond James Life Sciences and MedTech Conference will be available here (webcast link). For those not available to listen to the live broadcast, a replay will be archived for 30 days and available through the Investors page on www.precisionbiosciences.com.

On May 29, 2019 Medtronic plc (NYSE:MDT), the global leader in medical technology, reported that it will participate in the Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11, 2019, in Rancho Palos Verdes, California (Press release, Medtronic, MAY 29, 2019, View Source;p=RssLanding&cat=news&id=2399982 [SID1234536635]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Omar Ishrak, Medtronic chairman and chief executive officer, will answer questions about the company beginning at 11:20 a.m. PDT (1:20 p.m. CDT).

A live audio webcast of the session will be available on June 11, 2019, by clicking on the Investor Events link at View Source, and an archive of the session will be available on the same webpage later in the day.